^Stein C, Gieselmann V, Kreysing J, Schmidt B, Pohlmann R, Waheed A, Meyer HE, O'Brien JS, von Figura K. Cloning and expression of human arylsulfatase A. J. Biol. Chem. January 1989, 264 (2): 1252–9. PMID 2562955.
^Matzner U, Herbst E, Hedayati KK, Lüllmann-Rauch R, Wessig C, Schröder S, Eistrup C, Möller C, Fogh J, Gieselmann V. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy. Hum. Mol. Genet. May 2005, 14 (9): 1139–52. PMID 15772092. doi:10.1093/hmg/ddi126.
^Sevin C, Aubourg P, Cartier N. Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J. Inherit. Metab. Dis. April 2007, 30 (2): 175–83. PMID 17347913. doi:10.1007/s10545-007-0540-z.
Polten A; Fluharty AL; Fluharty CB; et al. Molecular basis of different forms of metachromatic leukodystrophy. N. Engl. J. Med. 1991, 324 (1): 18–22. PMID 1670590. doi:10.1056/NEJM199101033240104.
Geurts van Kessel AH. Regional localization of the genes coding for human ACO2, ARSA, and NAGA on chromosome 22. Cytogenet. Cell Genet. 1981, 28 (3): 169–72. PMID 7192199. doi:10.1159/000131527.
Barth ML, Fensom A, Harris A. Identification of seven novel mutations associated with metachromatic leukodystrophy. Hum. Mutat. 1995, 6 (2): 170–6. PMID 7581401. doi:10.1002/humu.1380060210.
Schmidt B, Selmer T, Ingendoh A, von Figura K. A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency. Cell. 1995, 82 (2): 271–8. PMID 7628016. doi:10.1016/0092-8674(95)90314-3.